Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report
AACE Endocrinology and Diabetes · 2026-10
DOI: 10.1016/j.aed.2026.09.027 ↗Kurz gefasst
Fallbericht in der Zeitschrift AACE Endocrinology and Diabetes, 2026-10. Verfasst von Larissa Bernardes Izza und 8 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Izza, L. B., Ferreira, H. B., Duarte, A. G., Guimarães, M. F. B. D. R., Rainato, G. S., Chaves, I. L., Cipriano, R. D. M., Saad, M. J. A., & Lauria, M. W. (2026). Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.09.027
Vancouver
Izza LB, Ferreira HB, Duarte AG, Guimarães MFBDR, Rainato GS, Chaves IL, et al. Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.09.027
BibTeX
@article{Izza2026,
author = {Izza, Larissa Bernardes and Ferreira, Humberto Batista and Duarte, Amanda Gonçalves and Guimarães, Maria Fernanda Brandão de Resende and Rainato, Gustavo Santos and Chaves, Isadora Lessa and Cipriano, Raphael de Magalhães and Saad, Mário José Abdala and Lauria, Marcio W.},
title = {Adjunctive Dapagliflozin and Rituximab in Type B Insulin Resistance: A Case Report},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.09.027}
}
EUVIMED